×
Back to Agenda
The Metamorphosis of Clinical Trials: Evolving Roles of Stakeholders in Digital Trials
Session Chair(s)
Josh Rose, MBA
Chief Executive Officer, Hawthorne Effect, United States
This session will examine the promise of virtual trials to address challenges of traditional site-based models by examining the evolving roles of study stakeholders, patients, investigators, and study managers, and how they improve study performance
Learning Objective : Describe the potential promise, benefits, and considerations of virtual clinical trials to address challenges to clinical trial conduct and participation; Define the evolution of stakeholder roles, existing and new, and the interplay between them, in virtual/direct to patient clinical trials; Apply insights to inform virtual trial design and planning.
Speaker(s)
Angela Botto-van Bemden, PHD
Director, OA Programs, Musculoskeletal Research International, United States
Jeff Kingsley, DO, MBA
Chief Executive Officer, IACT Health, United States
Christina Markus, JD
Partner, FDA and Life Sciences, King & Spalding LLP, United States
Robert Goldman, PHD
Head of Global Clinical Research & Medical Affairs, Sunovion, United States
Have an account?